» Articles » PMID: 7476093

Experimental Chlamydia Pneumoniae Infection in Mice: Effect of Reinfection and Passive Immunization

Overview
Journal Microb Pathog
Date 1995 Apr 1
PMID 7476093
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

NIH/S mice were infected intranasally with Chlamydia pneumoniae isolate Kajaani 6 and rechallenged after either 28 or 70 days. A partial resistance to reinfection, indicated by a reduced recovery of live organisms, was noted at both time points of rechallenge: positive isolations from lung homogenates and/or bronchoalveolar lavage fluids were observed in fewer mice and the yields of isolated chlamydiae remained smaller, as compared to primary infection. However, a previous infection did not confer any protection against inflammatory changes. A strong peribronchial and perivascular inflammation with infiltrating lymphocytes and plasma cells was noted in the lungs of primary infected, as well as reinfected, mice. The effect of passive immunization was also studied. When mice were given convalescent or hyperimmune sera intraperitoneally before inoculation, lower C. pneumoniae isolation yields were detected. As in the rechallenge experiment, marked inflammation could still be seen in the lungs, now with polymorphonuclear leukocyte infiltration. The results suggest that immunological reactions play a role in the pathogenesis of C. pneumoniae infection. Antibodies may be important in reducing the amount of infective elementary bodies, but complete clearing of C. pneumoniae could not be achieved in these experiments, even less a protection against inflammatory lung changes.

Citing Articles

Ectopic lymphoid tissue formation in the lungs of mice infected with Chlamydia pneumoniae is associated with epithelial macrophage inflammatory protein-2/CXCL2 expression.

Fitch P, Wheelhouse N, Bowles P, Paterson M, Longbottom D, Entrican G Clin Exp Immunol. 2010; 162(2):372-8.

PMID: 20840653 PMC: 2996604. DOI: 10.1111/j.1365-2249.2010.04231.x.


Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge.

Vuola J, Puurula V, Anttila M, Makela P, Rautonen N Infect Immun. 2000; 68(2):960-4.

PMID: 10639472 PMC: 97231. DOI: 10.1128/IAI.68.2.960-964.2000.


Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases.

Zeitlin L, Cone R, Whaley K Emerg Infect Dis. 1999; 5(1):54-64.

PMID: 10081672 PMC: 2627706. DOI: 10.3201/eid0501.990107.


Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection.

Penttila J, Anttila M, Puolakkainen M, Laurila A, Varkila K, Sarvas M Infect Immun. 1998; 66(11):5113-8.

PMID: 9784511 PMC: 108637. DOI: 10.1128/IAI.66.11.5113-5118.1998.


Rabbit model for Chlamydia pneumoniae infection.

Fong I, Chiu B, Viira E, Fong M, Jang D, Mahony J J Clin Microbiol. 1997; 35(1):48-52.

PMID: 8968879 PMC: 229510. DOI: 10.1128/jcm.35.1.48-52.1997.